|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | First observation of tropospheric nitrogen dioxide from the Environmental Trace Gases Monitoring Instrument onboard the GaoFen-5 satellite显示文摘The Environmental Trace Gases Monitoring Instrument(EMI)is the first Chinese satellite-borne UV–Vis spectrometer aiming to measure the distribution of atmospheric trace gases on a global scale.The EMI instrument onboard the GaoFen-5 satellite was launched on 9 May 2018.In this paper,we present the tropospheric nitrogen dioxide(NO2)vertical column density(VCD)retrieval algorithm dedicated to EMI measurement.We report the first successful retrieval of tropospheric NO_(2) VCD from the EMI instrument.Our retrieval improved the original EMI NO_(2) prototype algorithm by modifying the settings of the spectral fit and air mass factor calculations to account for the on-orbit instrumental performance changes.The retrieved EMI NO_(2) VCDs generally show good spatiotemporal agreement with the satellite-borne Ozone Monitoring Instrument and TROPOspheric Monitoring Instrument(correlation coefficient R of ~0.9,bias<50%).A comparison with ground-based MAX-DOAS(Multi-Axis Differential Optical Absorption Spectroscopy)observations also shows good correlation with an R of 0.82.The results indicate that the EMI NO_(2) retrieval algorithm derives reliable and precise results,and this algorithm can feasibly produce stable operational products that can contribute to global air pollution monitoring. | Chengxin Zhang Cheng Liu Ka Lok Chan Qihou Hu Haoran Liu Bo Li Chengzhi Xing Wei Tan Haijin Zhou Fuqi Si Jianguo Liu | 2020 | Light(Science & Applications)2020，9，1： | 11 |
| 2 | Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support显示文摘 | Lok SI Winkens B Goldschmeding R | | 0，，11： | 1 |
| 3 | Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure显示文摘 | Lok DJ Lok SI Bruggink-André de la Porte PW | | 0，，02： | 1 |
| 4 | Galectin-3 is an independent marker for ventricular remodeling and mortalith in patients with chronic heart failure显示文摘 | Lok DJ Lok SI Bruggink-Andréde la Porte PW | 2013 | Clin Res Cardiol2013，102，2： | 1 |
| 5 | Ga- leetin-3 is an independent marker for ventrieular remodeling and mortality in patients with chronic heart failure显示文摘 | Lok DJ Lok SI Bruggink-Andr6 de la Porte PW | 2013 | Clin Res Cardiol2013，102，2： | 1 |
| 6 | Incremental prognostic power of novel biomarkers(growth-differentiation factor-15,high-sensitivity C-reactive protein,galectin-3,and high-sensitivity troponinT)in patients with advanced chronic heart failure显示文摘 | Lok DJ Klip IT Lok SI | 2013 | Am J Cardiol2013，112，6： | 1 |
| 7 | Incremental Prognostic Power of Novel Biomarkers(Growth-Differentiation Factor-15, High- Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure显示文摘 | Lok D J Klip IT Lok SI | 2013 | American Journal of Cardiology2013，112，6： | 1 |
| 8 | Incremental prognostic power of novel biomarkers (growth-differentiation factor- 15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-t ) in patients with advanced chronic heart failure 显示文摘 | Lok D J Klip IT Lok SI | 2013 | Am J Cardiol2013，112，6： | 1 |
| 9 | Peripartum cardiomyopathy:the need for a national database显示文摘 | Lok SI Kirkels JH 9 KlQpping C | 2011 | Neth Heart J2011，19，3： | 1 |
| 10 | Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure显示文摘 | Lok DJ Lok SI Bruggink-AndréPW | 2013 | Clin Res Cardiol2013，102，2： | 1 |
| 11 | Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure显示文摘 | Lok DJ Lok SI Bruggink-Andre de la Porte PW | 2013 | Clin Res Cardiol2013，102，2： | 1 |
| 12 | Incremental prognostic power of novel biomarkers (growth differentiation factor-15,highsensitivity C-reactive protein,galectin-3,and high sensitivity troponin-T) in patients with advanced chronic heart failure显示文摘 | Lok DJ Klip IT Lok SI | | 0，，： | 1 |
| 13 | incremental prognostic power of novel biomarkers (growth-differentiation factor- 15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure显示文摘 | Lok DJ Klip IT Lok Si | 2013 | Am J Cardiol2013，112，6： | 1 |
| 14 | Peripartum cardiomyopathy:the need for a national database显示文摘 | Lok SI Kirkels JH Klpping C | 2011 | Neth Heart J2011，19，3： | 1 |
| 15 | Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure显示文摘 | Lok DJ Lok SI Bruggink-Andr de la Porte PW | 2013 | Clin Res Cardiol2013，102，： | 1 |
| 16 | Galectin-3 is an independent marker for ventricular re- modeling and mortality in patients with chronic heart fail- ure显示文摘 | Lok D J Lok SI Bruggink-Andr6: de la Porte PW | 2013 | Clin Res Cardiol2013，102，2： | 1 |
| 17 | Incremental prognostic nower of Novel biomarkers(growth-differentiation factor-15,high-sensitivity C-reactive protein,galectin-3,and highsensitivity troponin-T)in patients with advanced chronic heart failure显示文摘 | Lok DJ Klip IT Lok SI | 2013 | Am J Cardiol2013，112，6： | 1 |
| 18 | Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with nonischaemic dilated cardiomyopathy and decreases rapidly after left ventricular assist device support显示文摘 | Lok SI Winkens B Goldschmeding R | | 0，，11： | 1 |
| 19 | Circulating growth differentiation factor-15 correlates with myocardial fibrosis in patients with non-ischaemic dilated cardiomyopathy and decreases rapidly afterleft ventricular assist device support显示文摘 | Lok SI Winkens B Goldschmeding R | 2012 | Eur J Heart Fail2012，14，11： | 1 |
| 20 | Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure 显示文摘 | Lok D J Lok SI Bruggink-Andre de la Porte PW | 2013 | Clin Res Cardiol2013，102，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员